One of the largest British retailers posted annual figures that reflected pandemic's effects on the business
& Spencer, that has 254 full-line stores where it sells clothes,
homeware and food, posted a pre-tax profit before one-off items of 50.3 million
pounds, down from 403.1 million pounds reported for 2019-2020. In the food
sector, where space was open even during the pandemic, like-for-like sales went
up 1.3%. On the other hand, clothing and homeware sales plunged 31.5%, due to
the multiple COVID-19-related lockdowns. Also, the company’s profit for
2020-2021 slumped 88%, reflecting the collapse in clothing sales.
Chief Executive Steve
Rowe stated: "by going further and faster in our transformation during
this period of disruption...we have now moved beyond fixing the basics to forge
a reshaped M&S that is ready for the next phase."
For the future, Marks & Spencer forecast an underlying
pre-tax profit to recover to 300-350 million pounds in 2021-2022. Moreover, the
company is looking to fully remodel approx. 180 stores.
After the news hit the wires, the company's stock price went
This information prepared by ClickTrades.com is not an offer or a solicitation for the purpose of purchase or sale of any financial products referred to herein or to enter into any legal relations, nor an advice or a recommendation with respect to such financial products.
This information is prepared for general circulation. It does not have regard to the specific investment objectives, financial situation or the particular needs of any recipient.
You should independently evaluate each financial product and consider the suitability of such a financial product, by taking into account your specific investment objectives, financial situation or particular needs, and by consulting an independent financial adviser as needed, before dealing in any financial products mentioned in this document.
This information may not be published, circulated, reproduced or distributed in whole or in part to any other person without the Company’s prior written consent.
Past performance is not always indicative of likely or future performance. Any views or opinions presented are solely those of the author and do not necessarily represent those of ClickTrades.com.
AutoZone posts stronger-than-expected profit & sales
Amgen's Lumakras approved by the FDA